Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MALDI-TOF Mass Spectrometry01:19

MALDI-TOF Mass Spectrometry

5.4K
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 2026 global roadmap for textile-integrated wearable technologies in health.

Physiological measurement·2026
Same author

Apparent resolution of 27-mm Gallstones after traditional Persian medicine-based interventions: A case report.

Explore (New York, N.Y.)·2026
Same author

Shotgun metagenomic profiling reveals ecological and functional alterations of the oral microbiome in craniosynostosis.

Journal of oral microbiology·2026
Same author

Interpretable graph-based models on multimodal biomedical data integration: a technical review and benchmarking.

Nature communications·2026
Same author

Immunoinformatics-guided design of a multi-epitope vaccine targeting WISP1 for gastric cancer.

BMC biotechnology·2026
Same author

Distinguishing Ile/Leu Variant Ligands in the Immunopeptidome Using Hybrid EAD + CID Fragmentation (ExCID).

Analytical chemistry·2026
Same journal

Corrigendum to "Integrating experimental biology, computational methods, and artificial Intelligence in anticancer drug discovery: Bridging the translational Gap" [Comput. Biol. Med. 213 (2026) 111832].

Computers in biology and medicine·2026
Same journal

Organ dose optimization for a point-of-care forearm X-ray photon-counting CT.

Computers in biology and medicine·2026
Same journal

Physics-guided transformation of breathomic feature spaces into disease-specific representations for respiratory disease classification.

Computers in biology and medicine·2026
Same journal

An AI-driven deep learning pipeline for taxonomic classification and biodiversity assessment of deep-sea environmental DNA.

Computers in biology and medicine·2026
Same journal

Rapid personalisation of cardiovascular models using invasively measured right ventricular pressure.

Computers in biology and medicine·2026
Same journal

Biologically inspired mechanisms for enhancing robustness in EEG signal modeling: Challenges, opportunities, and perspectives.

Computers in biology and medicine·2026
See all related articles

Related Experiment Video

Updated: Sep 23, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.5K

Decoding clinical biomarker space of COVID-19: Exploring matrix factorization-based feature selection methods.

Farshad Saberi-Movahed1, Mahyar Mohammadifard2, Adel Mehrpooya3

  • 1College of Engineering, North Carolina State University, Raleigh, NC, 22606, USA.

Computers in Biology and Medicine
|May 15, 2022
PubMed
Summary
This summary is machine-generated.

Machine learning identified key blood test biomarkers for predicting COVID-19 patient outcomes. Arterial Blood Gas O2 Saturation and C-Reactive Protein indicate poor prognosis, aiding clinical decision-making.

Keywords:
COVID-19Clinical biomarkerDimensionality reductionFeature selectionMatrix factorization

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.7K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

924

Related Experiment Videos

Last Updated: Sep 23, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.5K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.7K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

924

Area of Science:

  • Biomedical Informatics
  • Computational Biology
  • Clinical Medicine

Background:

  • Effective patient triage is crucial for managing complex diseases like COVID-19 during pandemics.
  • Current methods relying on clinical presentation have limitations in accurately predicting patient prognosis.
  • There is a need for precise clinical biomarkers to guide critical care decisions in COVID-19 patients.

Purpose of the Study:

  • To develop a machine learning model for identifying blood test indicators of poor prognosis in COVID-19 patients.
  • To optimize clinical decision-making and patient management during infectious disease outbreaks.
  • To discover novel biomarkers predictive of morbidity and mortality in COVID-19.

Main Methods:

  • Utilized a two-scheme approach: Feature Selection using Matrix Factorization (MF) and Prognosis Classification with Random Forest.
  • Analyzed blood test data from a cohort of COVID-19 patients.
  • Applied machine learning algorithms to identify significant clinical indicators associated with adverse outcomes.

Main Results:

  • Identified Arterial Blood Gas (ABG) O2 Saturation and C-Reactive Protein (CRP) as the most significant predictors of poor prognosis.
  • The machine learning model demonstrated the capability to differentiate patients with varying risk levels.
  • Highlighted the predictive power of specific hematological markers in COVID-19 severity assessment.

Conclusions:

  • Arterial Blood Gas O2 Saturation and C-Reactive Protein are critical biomarkers for predicting COVID-19 patient prognosis.
  • The developed machine learning approach offers a quantitative method for optimizing clinical management systems.
  • This study provides a foundation for enhanced triage and personalized care strategies in pandemic scenarios.